USA: The Biden regime left behind the C-19 pandemic but saluted the Monkeypox.
On May 18, the US ordered $119M worth of Monkeypox vaccines. The firm that manufactures the vaccines is from Denmark, called Bavarian Nordic.
They produced and invoiced the US before the Monkeypox outbreak even appeared. Also, the vaccine has already been FDA-approved under JYNNEOS.
Biden Admin Places $119 Million Order For Monkeypox Vaccines As Virus Hits US https://t.co/tEk1itGgoS
— zerohedge (@zerohedge) May 20, 2022
Zero Hedge reported:
The Biden administration has placed an order for millions of doses of a vaccine intended to protect against smallpox and monkeypox, after the first case of monkeypox in the United States this year was confirmed in Massachusetts on May 18. Monkeypox, a viral disease typically limited to Africa, has been reported in several countries with more than 25 confirmed cases since the beginning of May.
Denmark-based biotech group Bavarian Nordic announced the order on May 18, which prompts the company to convert its bulk liquid smallpox vaccine into freeze-dried versions, which have an improved shelf life. The bulk vaccine has already been manufactured and invoiced under previous contracts with the U.S. government, the Bavarian Nordic stated. The vaccine is approved under the name “JYNNEOS” in the United States.
The order represents $119 million worth of the Jynneos vaccines, which would be manufactured and invoiced in 2023 and 2024.
Under the contract, the Biden administration has the option to place another order worth $180 million. That would allow for about 13 million freeze-dried doses of the Jynneos smallpox vaccine to be manufactured by around 2024 and 2025. The majority of the bulk vaccine for those doses has already been manufactured and invoiced, according to the company.
The Biden administration has placed an order for millions of doses of a vaccine intended to protect against smallpox and monkeypox. Stop the insanity. https://t.co/E1kH9mSqhh
— Noah V Malgeri for Congress (@Noah4NV) May 21, 2022
Are you ready for the next scam? #Corruption #WAKEUPWORLD #ENOUGH https://t.co/FP9yg5E2n1
— Sheila L. Ealey, E.dD. (@slealey53) May 20, 2022
The Epoch Times reported:
The Biden administration has placed an order for millions of doses of a vaccine intended to protect against smallpox and monkeypox, after the first case of monkeypox in the United States this year was confirmed in Massachusetts on May 18.
Monkeypox, a viral disease typically limited to Africa, has been reported in several countries with more than 25 confirmed cases since the beginning of May.
Denmark-based biotech group Bavarian Nordic announced the order on May 18, which prompts the company to convert its bulk liquid smallpox vaccine into freeze-dried versions, which have an improved shelf life. The bulk vaccine has already been manufactured and invoiced under previous contracts with the U.S. government, the Bavarian Nordic stated. The vaccine is approved under the name “JYNNEOS” in the United States.
The order represents $119 million worth of the Jynneos vaccines, which would be manufactured and invoiced in 2023 and 2024.
Join: 👉 https://t.me/acnewspatriots
The opinions expressed by contributors and/or content partners are their own and do not necessarily reflect the views of AC.NEWS
Disclaimer: This article may contain statements that reflect the opinion of the author. The contents of this article are of sole responsibility of the author(s). AC.News will not be responsible for any inaccurate or incorrect statement in this article www.ac.news websites contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of “fair use” in an effort to advance a better understanding of political, health, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than “fair use” you must request permission from the copyright owner. Reprinting this article: Non-commercial use OK. If you wish to use copyrighted material for purposes other than “fair use” you must request permission from the copyright owner.
Disclaimer: The information and opinions shared are for informational purposes only including, but not limited to, text, graphics, images and other material are not intended as medical advice or instruction. Nothing mentioned is intended to be a substitute for professional medical advice, diagnosis or treatment.
Discussion about this post